Advertisement
Advertisement

OCS

OCS logo

Oculis Holding AG Ordinary shares

31.37
USD
Sponsored
+0.96
+3.16%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

31.36

-0.02
-0.05%

Oculis Holding AG Ordinary shares Profile

About

Oculis Holding AG is a biopharmaceutical company which develops novel topical treatments for ophthalmic diseases for both back- and front-of-the-eye. Its product candidate includes OCS-01, OCS-02 and OCS-05. Oculis Holding AG is based in Zug, Switzerland.

Info & Links

CEO

Riad Sherif

Headquarters

BAHNHOFSTRASSE 20
ZUG, V8 6300, SWITZERLAND

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.oculis.com

Auditor

PricewaterhouseCoopers SA

Share holders

15

Employees

60

Oculis Holding AG Ordinary shares Statistics

Valuation Measures

Market Capitalization2

1.82B

Enterprise Value

1.74B

Enterprise Value/EBITDA(ttm)

-16.82

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

1.10K

Price to Book(mrq)

6.66

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-8173.41%

Profit Margin(ttm)

-8581.28%

Return on Equity(ttm)

-62.12%

Return on Invested Capital(ttm)

-63.52%

Return on Assets(ttm)

-49.74%

Income Statement

Revenue(ttm)

1.40M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

1.40M

EBITDA(ttm)3

-103.37M

Net Income Available to Common(ttm)

-119.31M

Diluted EPS(ttm)

-2.27

Share Statistics

Beta (5Y Monthly)

0.48

52-Week Change

76.63%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

22.30%

Balance Sheet

Total Cash(mrq)

283.34M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

2.87M

Total Debt/Equity(mrq)

1.18%

Current Ratio(mrq)

5.96%

Quick Ratio(mrq)

5.96%

Book Value Per Share(mrq)

4.08

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.53

Free Cash Flow(ytd)

-80.39M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement